The impact of OxyContin reformulation at the Sydney Medically Supervised Injecting Centre: Pros and cons
Author:
Publisher
Elsevier BV
Subject
Health Policy,Medicine (miscellaneous)
Reference25 articles.
1. Pharmacology of opioids II;Anaesthesia UK,2017
2. Oxycodone controlled released in cancer pain management;Biancofiore;Therapeutics and Clinical Risk Management,2006
3. An overview of the patterns of prescription opioid use, costs and related harms in Australia;Blanch;British Journal of Clinical Pharmacology,2014
4. Time series analysis: Forecasting and control;Box,1976
5. Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation. [Observational Study];Cassidy;Pain Medicine,2014
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interventions for reducing the prescribing of pharmaceutical opioids in Australia: are they effectively reducing opioid harm?;Medical Journal of Australia;2024-03-31
2. Twenty-year trends in pharmaceutical fentanyl and illicit fentanyl deaths, Australia 2001–2021;International Journal of Drug Policy;2022-11
3. Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study;International Journal of Drug Policy;2022-11
4. Characteristics of oxycodone‐related ambulance attendances: analysis of temporal trends and the effect of reformulation in Victoria, Australia from 2013 to 2018;Addiction;2021-01-04
5. Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes;International Journal of Drug Policy;2020-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3